Treatment for Pancreatic Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Pancreatic Cancer
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing two different combinations of drugs to see which is more effective and has fewer side effects in treating locally advanced pancreatic cancer.

Eligible Conditions
  • Pancreatic Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Time from first dose until subject has reached 90 days post last active study treatment

Day 90
Progression free survival
Day 90
Incidence of Adverse and Serious Adverse events will be captured (safety and tolerability)

Trial Safety

Trial Design

0 Treatment Group

20 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · Phase 1

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: time from first dose until subject has reached 90 days post last active study treatment

Who is running the clinical trial?

University of LouisvilleLead Sponsor
314 Previous Clinical Trials
72,920 Total Patients Enrolled
Robert Martin, MD, PhDPrincipal InvestigatorUniversity of Louisville
5 Previous Clinical Trials
18,058 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are eligible for the study if you are at least 18 years of age.
You have a tumor that is measurable.